Acceder

Publicaciones - HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL

Cargando...
Santaliestra M, Garrote M, Noya MS, Perez-Encinas M, Senin A, Perez-Lopez R, Ferrer-Marin F, Carreno-Tarragona G, Caballero G, Magro E, Velez P, Cortes Vazquez MA, Moreto A, Angona A, Pastor-Galan I, Guerra JM, Garcia Hernandez C, Mata MI, Stuckey R, Gomez-Casares MT, Fox L, Cuevas B, Garcia-Gutierrez V, Triguero A, Arellano-Rodrigo E, Hernandez-Boluda JC, Alvarez-Larran A. Prognostic value of response to first-line hydroxyurea according to IPSET stratification in essential thrombocythemia. Leukemia. 2024 Dec;38(12):2636-2643. doi: 10.1038/s41375-024-02416-2. Epub 2024 Sep 27. PubMed PMID: 39333760.
AÑO: 2024; IF: 13.4
39333760
Mingot-Castellano ME, Reguera-Ortega JL, Zafra Torres D, Hernani R, Lopez-Godino O, Guerreiro M, Herrero B, Lopez-Corral L, Luna A, Gonzalez-Pinedo L, Chinea-Rodriguez A, Africa-Martin A, Bailen R, Martinez-Cibrian N, Balsalobre P, Filaferro S, Alonso-Saladrigues A, Barba P, Perez-Martinez A, Calbacho M, Perez-Simon JA, Sanchez-Pina JM, On Behalf Of The Spanish Group Of Hematopoietic Transplant And Cell Therapy Geth-Tc. Use of Eltrombopag to Improve Thrombocytopenia and Tranfusion Requirement in Anti-CD19 CAR-T Cell-Treated Patients. J Clin Med. 2024 Aug 28;13(17):5117. doi: 10.3390/jcm13175117. PubMed PMID: 39274330; PubMed Central PMCID: PMC11396136.
AÑO: 2024; IF: 2.9
39274330
Marco-Ayala J, Asensi Canto P, Suarez M, Lamas B, Santiago M, Gomez I, Arnao M, Sanz J, Montava A, Sanz MA, de la Rubia J, Solves P. Single-Unit Transfusion Policy in Autologous Hematopoietic Stem Cell Transplantation: Less is Not Worse. Transfus Med Rev. 2024 Oct;38(4):150859. doi: 10.1016/j.tmrv.2024.150859. Epub 2024 Sep 14. PubMed PMID: 39383656.
AÑO: 2024; IF: 2.5
39383656
Paredero-Perez I, Jimenez-Fonseca P, Cano JM, Arrazubi V, Carmona-Bayonas A, Covela-Rua M, Fernandez-Montes A, Martin-Richard M, Girones-Sarrio R. State of the scientific evidence and recommendations for the management of older patients with gastric cancer. J Geriatr Oncol. 2024 Apr;15(3):101657. doi: 10.1016/j.jgo.2023.101657. Epub 2023 Nov 11. PubMed PMID: 37957106.
AÑO: 2024; IF: 2.7
37957106
Fonseca-Santos M, Bailen R, Lopez-Godino O, Herruzo-Delgado B, Bermudez MA, Garcia-Cadenas I, Huguet-Mas M, Ferra-Coll C, Esquirol A, Cortes-Rodriguez M, Yanez-Sansegundo L, Pascual-Cascon MJ, Heras I, Kwon M, Lopez-Corral L; Grupo Espanol de Trasplante Hematopoyetico y Terapia Celular. Characterization of Chronic Graft-versus-host Disease After Haploidentical Stem Cell Transplantation With Posttransplant Cyclophosphamide: A Study on Behalf of GETH-TC. Transplantation. 2024 Oct 1;108(10):2134-2143. doi: 10.1097/TP.0000000000005034. Epub 2024 Sep 24. PubMed PMID: 38685204.
AÑO: 2024; IF: 5.0
38685204
< AnteriorSiguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL